The risk of neuropathy associated with biological therapy in juvenile idiopathic arthritis children
Clinical Rheumatology · 2026
DOI: 10.1007/s10067-026-08226-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Rheumatology, 2026. Verfasst von Nourhan Elsayed Hebeshi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology, Rehabilitation and Physical Medicine, Faculty of Medicine, Tanta University, Tanta, Gharbia, Egypt. nourhanhebishy92@gmail.com. Hauptthemen laut MEDLINE: Arthritis, Juvenile, Antirheumatic Agents, Peripheral Nervous System Diseases, Biological Products. Die Arbeit nennt 31 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
OBJECTIVES: To evaluate the risk of neuropathy induced by biological drugs in children with juvenile idiopathic arthritis, clinically and by electrodiagnosis and ultrasonography. PATIENTS AND METHODS: Eighty juvenile idiopathic arthritis (JIA) patients were divided into 2 groups: 40 patients under treatment of biologic drugs and conventional disease-modifying antirheumatic drugs (DMARDs) in group I for at least 6 months, and 40 patients under treatment of conventional DMARDs only in group II. Assessment was done using pediatric-modified total neuropathy score (Ped-mTNS), electrodiagnostic (EDX) tests, and nerve ultrasound. RESULTS: There was a significant increase in Ped-mTNS, distal latency of peroneal nerve, and latency of tibial F wave and H-reflex, and a significant decrease in conduction velocity of both peroneal and tibial nerves in group I in comparison with group II. A positive correlation was detected between Ped-mTNS, cross-sectional area, and distal motor latency of the peroneal nerve, and between Ped-mTNS and tibial F wave latency, and a negative correlation between motor conduction velocity of the peroneal nerve and Ped-mTNS in group I. Absent H-reflex in 2 cases in group I. CONCLUSIONS: Demyelinating peripheral neuropathy can represent a rare adverse event in JIA children treated with biological agents. Key Points • The potential risks associated with biological therapy in JIA patients and the importance of neuropathy screening in these patients. • Nerve ultrasound exhibits lower sensitivity compared to nerve conduction studies for detecting early or subclinical demyelination, as morphological changes may not be apparent on imaging despite measurable functional neurophysiological impairment. • Nerve ultrasound has a complementary role in the diagnosis of peripheral neuropathy, but clinical examination and electrodiagnostic testing remain the actual gold standard for the evaluation of the peripheral nervous system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rheumatology, Rehabilitation and Physical Medicine, Faculty of Medicine, Tanta University, Tanta, Gharbia, Egypt. nourhanhebishy92@gmail.com.
- Rheumatology and Rehabilitation Department, Faculty of Medicine, Tanta University, Geish Street, Tanta, Gharbia, Egypt. nourhanhebishy92@gmail.com.
- Rheumatology, Rehabilitation and Physical Medicine, Faculty of Medicine, Tanta University, Tanta, Gharbia, Egypt.
Zitieren
APA
Hebeshi, N. E., Kassem, E. M., Hussein, M. S., & Elkholy, R. M. (2026). The risk of neuropathy associated with biological therapy in juvenile idiopathic arthritis children. Clinical Rheumatology. https://doi.org/10.1007/s10067-026-08226-4
Vancouver
Hebeshi NE, Kassem EM, Hussein MS, Elkholy RM. The risk of neuropathy associated with biological therapy in juvenile idiopathic arthritis children. Clinical Rheumatology. 2026. doi:10.1007/s10067-026-08226-4
BibTeX
@article{Hebeshi2026,
author = {Hebeshi, Nourhan Elsayed and Kassem, Elham Mohammad and Hussein, Manal Shawky and Elkholy, Radwa Mostafa},
title = {The risk of neuropathy associated with biological therapy in juvenile idiopathic arthritis children},
journal = {Clinical Rheumatology},
year = {2026},
doi = {10.1007/s10067-026-08226-4}
}
EUVIMED